Citigroup Inc Analysts Give Merck KGaA (MRK) a 116.00 Price Target


MRK has been the subject of a number of other research reports. Morgan Stanley set a 103.00 price objective on Merck KGaA and gave the stock a neutral rating in a research report on Tuesday, February 21st.



from Biotech News